The client has developed a proprietary software to identify the next generation of biomarkers and have already generated proof-of-concept data to achieve binary accuracy in a particular disease. The multi-institutional project team will evaluate the market opportunity of this biomarker approach for a particular neurodegenerative disorder. The team will utilize primary and secondary research to evaluate the following key areas: (1) market size, (2) unmet medical needs/research challenges, (3) development strategy include potential partnerships, and (4) competitive landscape. The team will construct a slide deck summarizing their findings and providing recommendations to guide the client’s business strategy. Throughout the project, team members will work closely with the company founder and leadership, an industry mentor, and BCBA leadership.